Evidence map›Paper›PMID 36837776›Full record

ArticleMetabolites2023

Meibomian Gland Assessment in Routine Ophthalmology Practice.

Igor Petriček, Martina Tomić, Tomislav Bulum, Dina Lešin Gaćina, Sania Vidas Pauk

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Igor PetričekDepartment of Ophthalmology, Zagreb University Hospital Center, 10000 Zagreb, Croatia.
Martina TomićVuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia.ORCID 0000-0002-7535-3631
Tomislav BulumSchool of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Dina Lešin GaćinaDepartment of Ophthalmology, Zagreb University Hospital Center, 10000 Zagreb, Croatia.
Sania Vidas PaukDepartment of Ophthalmology, Zagreb University Hospital Center, 10000 Zagreb, Croatia.ORCID 0000-0002-8229-7826
University Hospital Centre Zagreb · HRKlinička bolnica Merkur · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This cross-sectional study aimed to investigate the connection between meibomian gland (MG) excreta quantity and quality after MG expression (MGX), dry eye disease (DED) symptoms, and objective DED signs and to clarify the relationship between dry eye and MG function in DED pathophysiology. The study included 200 subjects, 100 with and 100 without dry eye symptoms. Schein questionnaire was used to determine the severity of dry eye symptoms and self-reported skin type for facial skin dryness self-evaluation. Objective dry eye signs were assessed by monitoring conjunctival hyperemia, lid parallel conjunctival folds (LIPCOF), tear break-up time (TBUT), fluorescein surface staining and digital MGX. Subjects with DED symptoms had significantly lower MG quantity scores than healthy controls (

Indexed as

dry eye syndromemeibomian glandmeibomian gland dysfunctionmeibomian gland lipidssebaceous glandssex hormones

Identifiers

PMID36837776
PMCPMC9964065
OpenAlexW4317616964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.